» Articles » PMID: 29805796

Thymoquinone Ameliorates Doxorubicin-Induced Cardiotoxicity in Swiss Albino Mice by Modulating Oxidative Damage and Cellular Inflammation

Overview
Publisher Wiley
Date 2018 May 29
PMID 29805796
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Thymoquinone is the active constituent of , having antioxidant and anti-inflammatory actions. In present study, we have analyzed the effects of thymoquinone on doxorubicin (DOX) induced cardiotoxicity in mice. In this experiment, thirty mice (25-35 gm) were divided into five groups (Groups A, B, C, D, and E) each containing six animals. Normal saline was given to a control group (Group A) for 14 days. Cardiotoxicity was induced by DOX (15 mg/kg, i.p.) in Group B, once on the 13th day of the study, and Groups C and D also received DOX (15 mg/kg, i.p.) and were then treated with thymoquinone (10 and 20 mg/kg, b/w, p.o.), respectively, for 14 days. Group E was given only thymoquione (20 mg/kg b/w, p.o.). A blood serum marker (AST, ALT, CK-MB, and LDH) and oxidative stress marker (LPO, GSH, CAT, SOD, GPx, GR, and GST) were evaluated. Results revealed that serum enzyme marker like aspartate aminotransferase (AST), creatinine kinase-MB (CKMB), and lactate dehydrogenase (LDH) were significantly elevated in Group B as compare to Group A. Similarly, the oxidative stress marker lipid peroxidation (LPO) was also elevated in Group B while the antioxidant enzyme catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase, and glutathione -transferase (CAT, SOD, GPx, GR, and GST) were also decreased in Group B. The treatment with thymoquinone 10 and 20 mg/kg resulted in a significant decrease in the serum marker and increase in the antioxidant enzymes. In this study, we have found that thymoquinone prevented DOX-induced cardiotoxicity by accelerating heart antioxidant defense mechanisms and down regulating the LPO levels towards normalcy in Groups C and D. The effect of doxorubicin increases the inflammatory cytokine (IL2) in Group B as compared to Group A, and it overcomes by the thymoquinone in Groups C and D. Thus, thymoquinone may have utility as a potential drug for cardiomyopathy.

Citing Articles

Investigating the cardioprotective potential of quercetin against tacrolimus-induced cardiotoxicity in Wistar rats: A mechanistic insights.

Verma A, Anwer T, Iqbal M, Gahlot V, Khan R, Sharma M Open Med (Wars). 2025; 20(1):20241130.

PMID: 40028266 PMC: 11868710. DOI: 10.1515/med-2024-1130.


Comparative Study of the Protective Effects of Citral, Thymoquinone, and Silymarin on Methotrexate-induced Cardiotoxicity in Rats.

Behdokht B, Foad N, Saeed N, Ahmadi N, Sakineh A J Pharmacopuncture. 2024; 27(3):245-252.

PMID: 39350925 PMC: 11439521. DOI: 10.3831/KPI.2024.27.3.245.


Efficacy of Thymoquinone and Hesperidin in Attenuating Cardiotoxicity from 5-Fluorouracil: Insights from In Vivo and In Silico Studies.

Farooq J, Sultana R, James J, Fathima C Z, Almutairy A, Hussain A Toxics. 2024; 12(9).

PMID: 39330616 PMC: 11435605. DOI: 10.3390/toxics12090688.


Comprehensive and updated review on anti-oxidant effects of and its constituent, thymoquinone, in various disorders.

Aslani M, Saadat S, Boskabady M Iran J Basic Med Sci. 2024; 27(8):923-951.

PMID: 38911247 PMC: 11193497. DOI: 10.22038/IJBMS.2024.75985.16453.


Thymoquinone attenuates diabetes-induced hepatic damage in rat via regulation of oxidative/nitrosative stress, apoptosis, and inflammatory cascade with molecular docking approach.

Hafez M, Ez Elarab S, Tohamy H, El-Far A Sci Rep. 2024; 14(1):13016.

PMID: 38844763 PMC: 11156670. DOI: 10.1038/s41598-024-62780-y.


References
1.
Talib W, AbuKhader M . Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954. Sci Pharm. 2013; 81(2):519-30. PMC: 3700079. DOI: 10.3797/scipharm.1211-15. View

2.
Doroshow J, Locker G, Baldinger J, Myers C . The effect of doxorubicin on hepatic and cardiac glutathione. Res Commun Chem Pathol Pharmacol. 1979; 26(2):285-95. View

3.
Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C . Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer. 2007; 121(11):2381-6. DOI: 10.1002/ijc.23192. View

4.
Safhi M, Alam M, Khuwaja G, Islam F, Hussain S, Fageeh M . REPEATED EXPOSURE OF SODIUM TELLURITE ON THE RAT LIVER AND ON THE POTENTIAL MECHANISMS OF THE METALLOID-INDUCED HEPATOTOXICITY. Acta Pol Pharm. 2016; 73(3):675-82. View

5.
Singal P, Segstro R, Singh R, Kutryk M . Changes in lysosomal morphology and enzyme activities during the development of adriamycin-induced cardiomyopathy. Can J Cardiol. 1985; 1(2):139-47. View